S. C. Hill

Sort by:

Hyper-IgE syndrome with recurrent infections--an autosomal dominant multisystem disorder.

B. Grimbacher, S. M. Holland, +6 authors Jennifer M Puck
The New England journal of medicine
1999

BACKGROUND The hyper-IgE syndrome with recurrent infections is a rare immunodeficiency characterized by recurrent skin and pulmonary abscesses and extremely elevated levels of IgE in serum.… (More)

Replacement therapy for inherited enzyme deficiency--macrophage-targeted glucocerebrosidase for Gaucher's disease.

Nick Barton, Roscoe O. Brady, +7 authors Charles E. Argoff
The New England journal of medicine
1991

BACKGROUND AND METHODS Gaucher's disease, the most prevalent of the sphingolipid storage disorders, is caused by a deficiency of the enzyme glucocerebrosidase (glucosylceramidase). Enzyme replacement… (More)

Enzyme therapy in type 1 Gaucher disease: comparative efficacy of mannose-terminated glucocerebrosidase from natural and recombinant sources.

Gregory Grabowski, Nick Barton, +7 authors Roscoe O. Brady
Annals of internal medicine
1995

OBJECTIVE To compare the efficacy of mannose-terminated glucocerbrosidase prepared from natural (alglucerase; Ceredase, Genzyme Corp., Cambridge, Massachusetts) and recombinant (imiglucerase;… (More)

Genetic diversity of human immunodeficiency virus type 2: evidence for distinct sequence subtypes with differences in virus biology.

F. Gao, Lixia Yue, +7 authors G. M. Shaw
Journal of virology
1994

The virulence properties of human immunodeficiency virus type 2 (HIV-2) are known to vary significantly and to range from relative attenuation in certain individuals to high-level pathogenicity in… (More)

Enzyme replacement therapy for Gaucher disease: skeletal responses to macrophage-targeted glucocerebrosidase.

David Rosenthal, Samuel H. Doppelt, +7 authors S. C. Hill
Pediatrics
1995

OBJECTIVES Reversal of the hematologic and visceral abnormalities characteristic of Gaucher disease, the most common lipid storage disorder, with biweekly infusions of macrophage-targeted… (More)

Gaucher disease: abdominal MR imaging findings in 46 patients.

S. C. Hill, Bonita M. Damaska, +4 authors Nick Barton
Radiology
1992

Abdominal magnetic resonance imaging findings were reviewed in 46 patients with Gaucher disease. All patients had hepatosplenomegaly at the time of initial imaging. Splenic nodules were present in 14… (More)

Gaucher disease: sonographic appearance of the spleen.

S. C. Hill, James W Reinig, John A. Barranger, J. Fink, Thomas H. Shawker
Radiology
1986

Ultrasonographic (US) examinations of the upper abdomen were performed in 80 patients with Gaucher disease. Of the 49 patients that had not undergone splenectomy, 47 had splenic enlargement. Sixteen… (More)

Sclerosing bone dysplasias: genetic and radioclinical features

F. M. Vanhoenacker, Luc H. L. De Beuckeleer, +4 authors Ann De Schepper
European Radiology
2000

Although knowledge of basic genetics in the field of sclerosing bone dysplasias is progressing, the radiologist still plays a pivotal role in the diagnosis of this relatively poorly understood group… (More)

Single-shot fluorescence spectra of individual micrometer-sized bioaerosols illuminated by a 351- or a 266-nm ultraviolet laser.

Yi Pan, Stefan Holler, +4 authors Jerold R. Bottiger
Optics letters
1999

Reproducible fluorescence spectra of individual 2- to 5-microm -diameter biological aerosol particles excited with a single shot from a Q -switched laser (266 or 351 nm) have been obtained with… (More)

Direct evidence that leukemic cells present HLA-associated immunogenic peptides derived from the BCR-ABL b3a2 fusion protein.

R. E. Clark, I. Anthony Dodi, +12 authors Jessica Madrigal
Blood
2001

The BCR-ABL oncogene is central in the pathogenesis of chronic myeloid leukemia (CML). Here, tandem nanospray mass spectrometry was used to demonstrate cell surface HLA-associated expression of the… (More)

Filter Results:

Publication Year

Publication Type

Co-author

Journals and Conferences